PT  - JOURNAL ARTICLE
AU  - Nishiura, Hiroshi
AU  - Kobayashi, Tetsuro
AU  - Miyama, Takeshi
AU  - Suzuki, Ayako
AU  - Jung, Sung-mok
AU  - Hayashi, Katsuma
AU  - Kinoshita, Ryo
AU  - Yang, Yichi
AU  - Yuan, Baoyin
AU  - Akhmetzhanov, Andrei R.
AU  - Linton, Natalie M.
TI  - Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19)
AID  - 10.1101/2020.02.03.20020248
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.02.03.20020248
4099  - http://medrxiv.org/content/early/2020/02/17/2020.02.03.20020248.short
4100  - http://medrxiv.org/content/early/2020/02/17/2020.02.03.20020248.full
AB  - A total of 565 Japanese citizens were evacuated from Wuhan, China to Japan. All passengers were screened for symptoms and also undertook reverse transcription polymerase chain reaction testing, identifying 5 asymptomatic and 7 symptomatic passengers testing positive for 2019-nCoV. We show that the screening result is suggestive of the asymptomatic ratio at 41.6%.Competing Interest StatementThe authors have declared no competing interest.Funding StatementH.N. received funding from the Japan Agency for Medical Research and Development (AMED) [grant number: JP18fk0108050]; the Japan Society for the Promotion of Science (JSPS) KAKENHI [grant numbers, H.N.: 17H04701, 17H05808, 18H04895 and 19H01074; R.K.: 18J21587], the Inamori Foundation, and the Japan Science and Technology Agency (JST) CREST program [grant number: JPMJCR1413]. NML receive graduate study scholarship from the Ministry of Education, Culture, Sports, Science and Technology, Japan.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available in the main text.